Global Cell-free Tumor DNA Detection Market Research Report 2024(Status and Outlook)
Report Overview:
Cell-free tumor DNA (circulating tumor DNA, ctDNA) testing, the so-called "liquid biopsy". ctDNA refers to the DNA released by tumor cells into the blood circulatory system, which contains information on tumor-derived mutations and gene variations. ctDNA is a tumor marker with broad application prospects, high sensitivity and high specificity, and is suitable for a variety of tumors, providing an opportunity for non-invasive sampling of tumors.
The Global Cell-free Tumor DNA Detection Market Size was estimated at USD 5632.82 million in 2023 and is projected to reach USD 9189.76 million by 2029, exhibiting a CAGR of 8.50% during the forecast period.
This report provides a deep insight into the global Cell-free Tumor DNA Detection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell-free Tumor DNA Detection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell-free Tumor DNA Detection market in any manner.
Global Cell-free Tumor DNA Detection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biocept Inc.
Bio-Rad Laboratories Inc.
Fluxion Biosciences Inc.
F. Hoffmann-La Roche AG
Sysmex Europe SE
Qiagen
NeoGenomics Laboratories Inc.
Menarini Silicon Biosystems
Illumina Inc.
Guardant Health Inc.
Shanghai Biotecan Medical Diagnostics Co.,Ltd.
Market Segmentation (by Type)
Droplet Digital Polymerase Chain Reaction
Tagged-Amplicon Deep Sequencing
Others
Market Segmentation (by Application)
Breast Cancer
Stomach Cancer
Liver Cancer
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell-free Tumor DNA Detection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Cell-free tumor DNA (circulating tumor DNA, ctDNA) testing, the so-called "liquid biopsy". ctDNA refers to the DNA released by tumor cells into the blood circulatory system, which contains information on tumor-derived mutations and gene variations. ctDNA is a tumor marker with broad application prospects, high sensitivity and high specificity, and is suitable for a variety of tumors, providing an opportunity for non-invasive sampling of tumors.
The Global Cell-free Tumor DNA Detection Market Size was estimated at USD 5632.82 million in 2023 and is projected to reach USD 9189.76 million by 2029, exhibiting a CAGR of 8.50% during the forecast period.
This report provides a deep insight into the global Cell-free Tumor DNA Detection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell-free Tumor DNA Detection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell-free Tumor DNA Detection market in any manner.
Global Cell-free Tumor DNA Detection Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biocept Inc.
Bio-Rad Laboratories Inc.
Fluxion Biosciences Inc.
F. Hoffmann-La Roche AG
Sysmex Europe SE
Qiagen
NeoGenomics Laboratories Inc.
Menarini Silicon Biosystems
Illumina Inc.
Guardant Health Inc.
Shanghai Biotecan Medical Diagnostics Co.,Ltd.
Market Segmentation (by Type)
Droplet Digital Polymerase Chain Reaction
Tagged-Amplicon Deep Sequencing
Others
Market Segmentation (by Application)
Breast Cancer
Stomach Cancer
Liver Cancer
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cell-free Tumor DNA Detection Market
- Overview of the regional outlook of the Cell-free Tumor DNA Detection Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell-free Tumor DNA Detection Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cell-free Tumor DNA Detection
1.2 Key Market Segments
1.2.1 Cell-free Tumor DNA Detection Segment by Type
1.2.2 Cell-free Tumor DNA Detection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL-FREE TUMOR DNA DETECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell-free Tumor DNA Detection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell-free Tumor DNA Detection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL-FREE TUMOR DNA DETECTION MARKET COMPETITIVE LANDSCAPE
3.1 Global Cell-free Tumor DNA Detection Sales by Manufacturers (2019-2024)
3.2 Global Cell-free Tumor DNA Detection Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell-free Tumor DNA Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell-free Tumor DNA Detection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell-free Tumor DNA Detection Sales Sites, Area Served, Product Type
3.6 Cell-free Tumor DNA Detection Market Competitive Situation and Trends
3.6.1 Cell-free Tumor DNA Detection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell-free Tumor DNA Detection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELL-FREE TUMOR DNA DETECTION INDUSTRY CHAIN ANALYSIS
4.1 Cell-free Tumor DNA Detection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL-FREE TUMOR DNA DETECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELL-FREE TUMOR DNA DETECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell-free Tumor DNA Detection Sales Market Share by Type (2019-2024)
6.3 Global Cell-free Tumor DNA Detection Market Size Market Share by Type (2019-2024)
6.4 Global Cell-free Tumor DNA Detection Price by Type (2019-2024)
7 CELL-FREE TUMOR DNA DETECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell-free Tumor DNA Detection Market Sales by Application (2019-2024)
7.3 Global Cell-free Tumor DNA Detection Market Size (M USD) by Application (2019-2024)
7.4 Global Cell-free Tumor DNA Detection Sales Growth Rate by Application (2019-2024)
8 CELL-FREE TUMOR DNA DETECTION MARKET SEGMENTATION BY REGION
8.1 Global Cell-free Tumor DNA Detection Sales by Region
8.1.1 Global Cell-free Tumor DNA Detection Sales by Region
8.1.2 Global Cell-free Tumor DNA Detection Sales Market Share by Region
8.2 North America
8.2.1 North America Cell-free Tumor DNA Detection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell-free Tumor DNA Detection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell-free Tumor DNA Detection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell-free Tumor DNA Detection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell-free Tumor DNA Detection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Biocept Inc.
9.1.1 Biocept Inc. Cell-free Tumor DNA Detection Basic Information
9.1.2 Biocept Inc. Cell-free Tumor DNA Detection Product Overview
9.1.3 Biocept Inc. Cell-free Tumor DNA Detection Product Market Performance
9.1.4 Biocept Inc. Business Overview
9.1.5 Biocept Inc. Cell-free Tumor DNA Detection SWOT Analysis
9.1.6 Biocept Inc. Recent Developments
9.2 Bio-Rad Laboratories Inc.
9.2.1 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Basic Information
9.2.2 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Overview
9.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Market Performance
9.2.4 Bio-Rad Laboratories Inc. Business Overview
9.2.5 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection SWOT Analysis
9.2.6 Bio-Rad Laboratories Inc. Recent Developments
9.3 Fluxion Biosciences Inc.
9.3.1 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Basic Information
9.3.2 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Overview
9.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Market Performance
9.3.4 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection SWOT Analysis
9.3.5 Fluxion Biosciences Inc. Business Overview
9.3.6 Fluxion Biosciences Inc. Recent Developments
9.4 F. Hoffmann-La Roche AG
9.4.1 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Basic Information
9.4.2 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Overview
9.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Market Performance
9.4.4 F. Hoffmann-La Roche AG Business Overview
9.4.5 F. Hoffmann-La Roche AG Recent Developments
9.5 Sysmex Europe SE
9.5.1 Sysmex Europe SE Cell-free Tumor DNA Detection Basic Information
9.5.2 Sysmex Europe SE Cell-free Tumor DNA Detection Product Overview
9.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Product Market Performance
9.5.4 Sysmex Europe SE Business Overview
9.5.5 Sysmex Europe SE Recent Developments
9.6 Qiagen
9.6.1 Qiagen Cell-free Tumor DNA Detection Basic Information
9.6.2 Qiagen Cell-free Tumor DNA Detection Product Overview
9.6.3 Qiagen Cell-free Tumor DNA Detection Product Market Performance
9.6.4 Qiagen Business Overview
9.6.5 Qiagen Recent Developments
9.7 NeoGenomics Laboratories Inc.
9.7.1 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Basic Information
9.7.2 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Overview
9.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Market Performance
9.7.4 NeoGenomics Laboratories Inc. Business Overview
9.7.5 NeoGenomics Laboratories Inc. Recent Developments
9.8 Menarini Silicon Biosystems
9.8.1 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Basic Information
9.8.2 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Overview
9.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Market Performance
9.8.4 Menarini Silicon Biosystems Business Overview
9.8.5 Menarini Silicon Biosystems Recent Developments
9.9 Illumina Inc.
9.9.1 Illumina Inc. Cell-free Tumor DNA Detection Basic Information
9.9.2 Illumina Inc. Cell-free Tumor DNA Detection Product Overview
9.9.3 Illumina Inc. Cell-free Tumor DNA Detection Product Market Performance
9.9.4 Illumina Inc. Business Overview
9.9.5 Illumina Inc. Recent Developments
9.10 Guardant Health Inc.
9.10.1 Guardant Health Inc. Cell-free Tumor DNA Detection Basic Information
9.10.2 Guardant Health Inc. Cell-free Tumor DNA Detection Product Overview
9.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Product Market Performance
9.10.4 Guardant Health Inc. Business Overview
9.10.5 Guardant Health Inc. Recent Developments
9.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
9.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Basic Information
9.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Overview
9.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Market Performance
9.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Business Overview
9.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments
10 CELL-FREE TUMOR DNA DETECTION MARKET FORECAST BY REGION
10.1 Global Cell-free Tumor DNA Detection Market Size Forecast
10.2 Global Cell-free Tumor DNA Detection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell-free Tumor DNA Detection Market Size Forecast by Country
10.2.3 Asia Pacific Cell-free Tumor DNA Detection Market Size Forecast by Region
10.2.4 South America Cell-free Tumor DNA Detection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell-free Tumor DNA Detection by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cell-free Tumor DNA Detection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell-free Tumor DNA Detection by Type (2025-2030)
11.1.2 Global Cell-free Tumor DNA Detection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell-free Tumor DNA Detection by Type (2025-2030)
11.2 Global Cell-free Tumor DNA Detection Market Forecast by Application (2025-2030)
11.2.1 Global Cell-free Tumor DNA Detection Sales (K Units) Forecast by Application
11.2.2 Global Cell-free Tumor DNA Detection Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cell-free Tumor DNA Detection
1.2 Key Market Segments
1.2.1 Cell-free Tumor DNA Detection Segment by Type
1.2.2 Cell-free Tumor DNA Detection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL-FREE TUMOR DNA DETECTION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell-free Tumor DNA Detection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell-free Tumor DNA Detection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL-FREE TUMOR DNA DETECTION MARKET COMPETITIVE LANDSCAPE
3.1 Global Cell-free Tumor DNA Detection Sales by Manufacturers (2019-2024)
3.2 Global Cell-free Tumor DNA Detection Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell-free Tumor DNA Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell-free Tumor DNA Detection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell-free Tumor DNA Detection Sales Sites, Area Served, Product Type
3.6 Cell-free Tumor DNA Detection Market Competitive Situation and Trends
3.6.1 Cell-free Tumor DNA Detection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell-free Tumor DNA Detection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELL-FREE TUMOR DNA DETECTION INDUSTRY CHAIN ANALYSIS
4.1 Cell-free Tumor DNA Detection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL-FREE TUMOR DNA DETECTION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELL-FREE TUMOR DNA DETECTION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell-free Tumor DNA Detection Sales Market Share by Type (2019-2024)
6.3 Global Cell-free Tumor DNA Detection Market Size Market Share by Type (2019-2024)
6.4 Global Cell-free Tumor DNA Detection Price by Type (2019-2024)
7 CELL-FREE TUMOR DNA DETECTION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell-free Tumor DNA Detection Market Sales by Application (2019-2024)
7.3 Global Cell-free Tumor DNA Detection Market Size (M USD) by Application (2019-2024)
7.4 Global Cell-free Tumor DNA Detection Sales Growth Rate by Application (2019-2024)
8 CELL-FREE TUMOR DNA DETECTION MARKET SEGMENTATION BY REGION
8.1 Global Cell-free Tumor DNA Detection Sales by Region
8.1.1 Global Cell-free Tumor DNA Detection Sales by Region
8.1.2 Global Cell-free Tumor DNA Detection Sales Market Share by Region
8.2 North America
8.2.1 North America Cell-free Tumor DNA Detection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell-free Tumor DNA Detection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell-free Tumor DNA Detection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell-free Tumor DNA Detection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell-free Tumor DNA Detection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Biocept Inc.
9.1.1 Biocept Inc. Cell-free Tumor DNA Detection Basic Information
9.1.2 Biocept Inc. Cell-free Tumor DNA Detection Product Overview
9.1.3 Biocept Inc. Cell-free Tumor DNA Detection Product Market Performance
9.1.4 Biocept Inc. Business Overview
9.1.5 Biocept Inc. Cell-free Tumor DNA Detection SWOT Analysis
9.1.6 Biocept Inc. Recent Developments
9.2 Bio-Rad Laboratories Inc.
9.2.1 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Basic Information
9.2.2 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Overview
9.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Market Performance
9.2.4 Bio-Rad Laboratories Inc. Business Overview
9.2.5 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection SWOT Analysis
9.2.6 Bio-Rad Laboratories Inc. Recent Developments
9.3 Fluxion Biosciences Inc.
9.3.1 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Basic Information
9.3.2 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Overview
9.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Market Performance
9.3.4 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection SWOT Analysis
9.3.5 Fluxion Biosciences Inc. Business Overview
9.3.6 Fluxion Biosciences Inc. Recent Developments
9.4 F. Hoffmann-La Roche AG
9.4.1 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Basic Information
9.4.2 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Overview
9.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Market Performance
9.4.4 F. Hoffmann-La Roche AG Business Overview
9.4.5 F. Hoffmann-La Roche AG Recent Developments
9.5 Sysmex Europe SE
9.5.1 Sysmex Europe SE Cell-free Tumor DNA Detection Basic Information
9.5.2 Sysmex Europe SE Cell-free Tumor DNA Detection Product Overview
9.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Product Market Performance
9.5.4 Sysmex Europe SE Business Overview
9.5.5 Sysmex Europe SE Recent Developments
9.6 Qiagen
9.6.1 Qiagen Cell-free Tumor DNA Detection Basic Information
9.6.2 Qiagen Cell-free Tumor DNA Detection Product Overview
9.6.3 Qiagen Cell-free Tumor DNA Detection Product Market Performance
9.6.4 Qiagen Business Overview
9.6.5 Qiagen Recent Developments
9.7 NeoGenomics Laboratories Inc.
9.7.1 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Basic Information
9.7.2 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Overview
9.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Market Performance
9.7.4 NeoGenomics Laboratories Inc. Business Overview
9.7.5 NeoGenomics Laboratories Inc. Recent Developments
9.8 Menarini Silicon Biosystems
9.8.1 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Basic Information
9.8.2 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Overview
9.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Market Performance
9.8.4 Menarini Silicon Biosystems Business Overview
9.8.5 Menarini Silicon Biosystems Recent Developments
9.9 Illumina Inc.
9.9.1 Illumina Inc. Cell-free Tumor DNA Detection Basic Information
9.9.2 Illumina Inc. Cell-free Tumor DNA Detection Product Overview
9.9.3 Illumina Inc. Cell-free Tumor DNA Detection Product Market Performance
9.9.4 Illumina Inc. Business Overview
9.9.5 Illumina Inc. Recent Developments
9.10 Guardant Health Inc.
9.10.1 Guardant Health Inc. Cell-free Tumor DNA Detection Basic Information
9.10.2 Guardant Health Inc. Cell-free Tumor DNA Detection Product Overview
9.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Product Market Performance
9.10.4 Guardant Health Inc. Business Overview
9.10.5 Guardant Health Inc. Recent Developments
9.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
9.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Basic Information
9.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Overview
9.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Market Performance
9.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Business Overview
9.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments
10 CELL-FREE TUMOR DNA DETECTION MARKET FORECAST BY REGION
10.1 Global Cell-free Tumor DNA Detection Market Size Forecast
10.2 Global Cell-free Tumor DNA Detection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell-free Tumor DNA Detection Market Size Forecast by Country
10.2.3 Asia Pacific Cell-free Tumor DNA Detection Market Size Forecast by Region
10.2.4 South America Cell-free Tumor DNA Detection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell-free Tumor DNA Detection by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cell-free Tumor DNA Detection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell-free Tumor DNA Detection by Type (2025-2030)
11.1.2 Global Cell-free Tumor DNA Detection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell-free Tumor DNA Detection by Type (2025-2030)
11.2 Global Cell-free Tumor DNA Detection Market Forecast by Application (2025-2030)
11.2.1 Global Cell-free Tumor DNA Detection Sales (K Units) Forecast by Application
11.2.2 Global Cell-free Tumor DNA Detection Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell-free Tumor DNA Detection Market Size Comparison by Region (M USD)
Table 5. Global Cell-free Tumor DNA Detection Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell-free Tumor DNA Detection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell-free Tumor DNA Detection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell-free Tumor DNA Detection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-free Tumor DNA Detection as of 2022)
Table 10. Global Market Cell-free Tumor DNA Detection Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell-free Tumor DNA Detection Sales Sites and Area Served
Table 12. Manufacturers Cell-free Tumor DNA Detection Product Type
Table 13. Global Cell-free Tumor DNA Detection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell-free Tumor DNA Detection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell-free Tumor DNA Detection Market Challenges
Table 22. Global Cell-free Tumor DNA Detection Sales by Type (K Units)
Table 23. Global Cell-free Tumor DNA Detection Market Size by Type (M USD)
Table 24. Global Cell-free Tumor DNA Detection Sales (K Units) by Type (2019-2024)
Table 25. Global Cell-free Tumor DNA Detection Sales Market Share by Type (2019-2024)
Table 26. Global Cell-free Tumor DNA Detection Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell-free Tumor DNA Detection Market Size Share by Type (2019-2024)
Table 28. Global Cell-free Tumor DNA Detection Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell-free Tumor DNA Detection Sales (K Units) by Application
Table 30. Global Cell-free Tumor DNA Detection Market Size by Application
Table 31. Global Cell-free Tumor DNA Detection Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell-free Tumor DNA Detection Sales Market Share by Application (2019-2024)
Table 33. Global Cell-free Tumor DNA Detection Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell-free Tumor DNA Detection Market Share by Application (2019-2024)
Table 35. Global Cell-free Tumor DNA Detection Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell-free Tumor DNA Detection Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell-free Tumor DNA Detection Sales Market Share by Region (2019-2024)
Table 38. North America Cell-free Tumor DNA Detection Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell-free Tumor DNA Detection Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell-free Tumor DNA Detection Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell-free Tumor DNA Detection Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell-free Tumor DNA Detection Sales by Region (2019-2024) & (K Units)
Table 43. Biocept Inc. Cell-free Tumor DNA Detection Basic Information
Table 44. Biocept Inc. Cell-free Tumor DNA Detection Product Overview
Table 45. Biocept Inc. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Biocept Inc. Business Overview
Table 47. Biocept Inc. Cell-free Tumor DNA Detection SWOT Analysis
Table 48. Biocept Inc. Recent Developments
Table 49. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Basic Information
Table 50. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Overview
Table 51. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bio-Rad Laboratories Inc. Business Overview
Table 53. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection SWOT Analysis
Table 54. Bio-Rad Laboratories Inc. Recent Developments
Table 55. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Basic Information
Table 56. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Overview
Table 57. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection SWOT Analysis
Table 59. Fluxion Biosciences Inc. Business Overview
Table 60. Fluxion Biosciences Inc. Recent Developments
Table 61. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Basic Information
Table 62. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Overview
Table 63. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. F. Hoffmann-La Roche AG Business Overview
Table 65. F. Hoffmann-La Roche AG Recent Developments
Table 66. Sysmex Europe SE Cell-free Tumor DNA Detection Basic Information
Table 67. Sysmex Europe SE Cell-free Tumor DNA Detection Product Overview
Table 68. Sysmex Europe SE Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Sysmex Europe SE Business Overview
Table 70. Sysmex Europe SE Recent Developments
Table 71. Qiagen Cell-free Tumor DNA Detection Basic Information
Table 72. Qiagen Cell-free Tumor DNA Detection Product Overview
Table 73. Qiagen Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Qiagen Business Overview
Table 75. Qiagen Recent Developments
Table 76. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Basic Information
Table 77. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Overview
Table 78. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. NeoGenomics Laboratories Inc. Business Overview
Table 80. NeoGenomics Laboratories Inc. Recent Developments
Table 81. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Basic Information
Table 82. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Overview
Table 83. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Menarini Silicon Biosystems Business Overview
Table 85. Menarini Silicon Biosystems Recent Developments
Table 86. Illumina Inc. Cell-free Tumor DNA Detection Basic Information
Table 87. Illumina Inc. Cell-free Tumor DNA Detection Product Overview
Table 88. Illumina Inc. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Illumina Inc. Business Overview
Table 90. Illumina Inc. Recent Developments
Table 91. Guardant Health Inc. Cell-free Tumor DNA Detection Basic Information
Table 92. Guardant Health Inc. Cell-free Tumor DNA Detection Product Overview
Table 93. Guardant Health Inc. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Guardant Health Inc. Business Overview
Table 95. Guardant Health Inc. Recent Developments
Table 96. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Basic Information
Table 97. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Overview
Table 98. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Business Overview
Table 100. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments
Table 101. Global Cell-free Tumor DNA Detection Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Cell-free Tumor DNA Detection Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Cell-free Tumor DNA Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Cell-free Tumor DNA Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Cell-free Tumor DNA Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Cell-free Tumor DNA Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Cell-free Tumor DNA Detection Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Cell-free Tumor DNA Detection Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Cell-free Tumor DNA Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Cell-free Tumor DNA Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Cell-free Tumor DNA Detection Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Cell-free Tumor DNA Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Cell-free Tumor DNA Detection Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Cell-free Tumor DNA Detection Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Cell-free Tumor DNA Detection Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Cell-free Tumor DNA Detection Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Cell-free Tumor DNA Detection Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell-free Tumor DNA Detection Market Size Comparison by Region (M USD)
Table 5. Global Cell-free Tumor DNA Detection Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell-free Tumor DNA Detection Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell-free Tumor DNA Detection Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell-free Tumor DNA Detection Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-free Tumor DNA Detection as of 2022)
Table 10. Global Market Cell-free Tumor DNA Detection Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell-free Tumor DNA Detection Sales Sites and Area Served
Table 12. Manufacturers Cell-free Tumor DNA Detection Product Type
Table 13. Global Cell-free Tumor DNA Detection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell-free Tumor DNA Detection
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell-free Tumor DNA Detection Market Challenges
Table 22. Global Cell-free Tumor DNA Detection Sales by Type (K Units)
Table 23. Global Cell-free Tumor DNA Detection Market Size by Type (M USD)
Table 24. Global Cell-free Tumor DNA Detection Sales (K Units) by Type (2019-2024)
Table 25. Global Cell-free Tumor DNA Detection Sales Market Share by Type (2019-2024)
Table 26. Global Cell-free Tumor DNA Detection Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell-free Tumor DNA Detection Market Size Share by Type (2019-2024)
Table 28. Global Cell-free Tumor DNA Detection Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell-free Tumor DNA Detection Sales (K Units) by Application
Table 30. Global Cell-free Tumor DNA Detection Market Size by Application
Table 31. Global Cell-free Tumor DNA Detection Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell-free Tumor DNA Detection Sales Market Share by Application (2019-2024)
Table 33. Global Cell-free Tumor DNA Detection Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell-free Tumor DNA Detection Market Share by Application (2019-2024)
Table 35. Global Cell-free Tumor DNA Detection Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell-free Tumor DNA Detection Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell-free Tumor DNA Detection Sales Market Share by Region (2019-2024)
Table 38. North America Cell-free Tumor DNA Detection Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell-free Tumor DNA Detection Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell-free Tumor DNA Detection Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell-free Tumor DNA Detection Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell-free Tumor DNA Detection Sales by Region (2019-2024) & (K Units)
Table 43. Biocept Inc. Cell-free Tumor DNA Detection Basic Information
Table 44. Biocept Inc. Cell-free Tumor DNA Detection Product Overview
Table 45. Biocept Inc. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Biocept Inc. Business Overview
Table 47. Biocept Inc. Cell-free Tumor DNA Detection SWOT Analysis
Table 48. Biocept Inc. Recent Developments
Table 49. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Basic Information
Table 50. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Overview
Table 51. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bio-Rad Laboratories Inc. Business Overview
Table 53. Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection SWOT Analysis
Table 54. Bio-Rad Laboratories Inc. Recent Developments
Table 55. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Basic Information
Table 56. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Overview
Table 57. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Fluxion Biosciences Inc. Cell-free Tumor DNA Detection SWOT Analysis
Table 59. Fluxion Biosciences Inc. Business Overview
Table 60. Fluxion Biosciences Inc. Recent Developments
Table 61. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Basic Information
Table 62. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Overview
Table 63. F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. F. Hoffmann-La Roche AG Business Overview
Table 65. F. Hoffmann-La Roche AG Recent Developments
Table 66. Sysmex Europe SE Cell-free Tumor DNA Detection Basic Information
Table 67. Sysmex Europe SE Cell-free Tumor DNA Detection Product Overview
Table 68. Sysmex Europe SE Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Sysmex Europe SE Business Overview
Table 70. Sysmex Europe SE Recent Developments
Table 71. Qiagen Cell-free Tumor DNA Detection Basic Information
Table 72. Qiagen Cell-free Tumor DNA Detection Product Overview
Table 73. Qiagen Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Qiagen Business Overview
Table 75. Qiagen Recent Developments
Table 76. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Basic Information
Table 77. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Overview
Table 78. NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. NeoGenomics Laboratories Inc. Business Overview
Table 80. NeoGenomics Laboratories Inc. Recent Developments
Table 81. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Basic Information
Table 82. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Overview
Table 83. Menarini Silicon Biosystems Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Menarini Silicon Biosystems Business Overview
Table 85. Menarini Silicon Biosystems Recent Developments
Table 86. Illumina Inc. Cell-free Tumor DNA Detection Basic Information
Table 87. Illumina Inc. Cell-free Tumor DNA Detection Product Overview
Table 88. Illumina Inc. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Illumina Inc. Business Overview
Table 90. Illumina Inc. Recent Developments
Table 91. Guardant Health Inc. Cell-free Tumor DNA Detection Basic Information
Table 92. Guardant Health Inc. Cell-free Tumor DNA Detection Product Overview
Table 93. Guardant Health Inc. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Guardant Health Inc. Business Overview
Table 95. Guardant Health Inc. Recent Developments
Table 96. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Basic Information
Table 97. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Overview
Table 98. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Business Overview
Table 100. Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments
Table 101. Global Cell-free Tumor DNA Detection Sales Forecast by Region (2025-2030) & (K Units)
Table 102. Global Cell-free Tumor DNA Detection Market Size Forecast by Region (2025-2030) & (M USD)
Table 103. North America Cell-free Tumor DNA Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 104. North America Cell-free Tumor DNA Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 105. Europe Cell-free Tumor DNA Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 106. Europe Cell-free Tumor DNA Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 107. Asia Pacific Cell-free Tumor DNA Detection Sales Forecast by Region (2025-2030) & (K Units)
Table 108. Asia Pacific Cell-free Tumor DNA Detection Market Size Forecast by Region (2025-2030) & (M USD)
Table 109. South America Cell-free Tumor DNA Detection Sales Forecast by Country (2025-2030) & (K Units)
Table 110. South America Cell-free Tumor DNA Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 111. Middle East and Africa Cell-free Tumor DNA Detection Consumption Forecast by Country (2025-2030) & (Units)
Table 112. Middle East and Africa Cell-free Tumor DNA Detection Market Size Forecast by Country (2025-2030) & (M USD)
Table 113. Global Cell-free Tumor DNA Detection Sales Forecast by Type (2025-2030) & (K Units)
Table 114. Global Cell-free Tumor DNA Detection Market Size Forecast by Type (2025-2030) & (M USD)
Table 115. Global Cell-free Tumor DNA Detection Price Forecast by Type (2025-2030) & (USD/Unit)
Table 116. Global Cell-free Tumor DNA Detection Sales (K Units) Forecast by Application (2025-2030)
Table 117. Global Cell-free Tumor DNA Detection Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cell-free Tumor DNA Detection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell-free Tumor DNA Detection Market Size (M USD), 2019-2030
Figure 5. Global Cell-free Tumor DNA Detection Market Size (M USD) (2019-2030)
Figure 6. Global Cell-free Tumor DNA Detection Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell-free Tumor DNA Detection Market Size by Country (M USD)
Figure 11. Cell-free Tumor DNA Detection Sales Share by Manufacturers in 2023
Figure 12. Global Cell-free Tumor DNA Detection Revenue Share by Manufacturers in 2023
Figure 13. Cell-free Tumor DNA Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell-free Tumor DNA Detection Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell-free Tumor DNA Detection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell-free Tumor DNA Detection Market Share by Type
Figure 18. Sales Market Share of Cell-free Tumor DNA Detection by Type (2019-2024)
Figure 19. Sales Market Share of Cell-free Tumor DNA Detection by Type in 2023
Figure 20. Market Size Share of Cell-free Tumor DNA Detection by Type (2019-2024)
Figure 21. Market Size Market Share of Cell-free Tumor DNA Detection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell-free Tumor DNA Detection Market Share by Application
Figure 24. Global Cell-free Tumor DNA Detection Sales Market Share by Application (2019-2024)
Figure 25. Global Cell-free Tumor DNA Detection Sales Market Share by Application in 2023
Figure 26. Global Cell-free Tumor DNA Detection Market Share by Application (2019-2024)
Figure 27. Global Cell-free Tumor DNA Detection Market Share by Application in 2023
Figure 28. Global Cell-free Tumor DNA Detection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell-free Tumor DNA Detection Sales Market Share by Region (2019-2024)
Figure 30. North America Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell-free Tumor DNA Detection Sales Market Share by Country in 2023
Figure 32. U.S. Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell-free Tumor DNA Detection Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell-free Tumor DNA Detection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell-free Tumor DNA Detection Sales Market Share by Country in 2023
Figure 37. Germany Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell-free Tumor DNA Detection Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell-free Tumor DNA Detection Sales Market Share by Region in 2023
Figure 44. China Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell-free Tumor DNA Detection Sales and Growth Rate (K Units)
Figure 50. South America Cell-free Tumor DNA Detection Sales Market Share by Country in 2023
Figure 51. Brazil Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell-free Tumor DNA Detection Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell-free Tumor DNA Detection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell-free Tumor DNA Detection Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cell-free Tumor DNA Detection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cell-free Tumor DNA Detection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cell-free Tumor DNA Detection Market Share Forecast by Type (2025-2030)
Figure 65. Global Cell-free Tumor DNA Detection Sales Forecast by Application (2025-2030)
Figure 66. Global Cell-free Tumor DNA Detection Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Cell-free Tumor DNA Detection
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell-free Tumor DNA Detection Market Size (M USD), 2019-2030
Figure 5. Global Cell-free Tumor DNA Detection Market Size (M USD) (2019-2030)
Figure 6. Global Cell-free Tumor DNA Detection Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell-free Tumor DNA Detection Market Size by Country (M USD)
Figure 11. Cell-free Tumor DNA Detection Sales Share by Manufacturers in 2023
Figure 12. Global Cell-free Tumor DNA Detection Revenue Share by Manufacturers in 2023
Figure 13. Cell-free Tumor DNA Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell-free Tumor DNA Detection Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell-free Tumor DNA Detection Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell-free Tumor DNA Detection Market Share by Type
Figure 18. Sales Market Share of Cell-free Tumor DNA Detection by Type (2019-2024)
Figure 19. Sales Market Share of Cell-free Tumor DNA Detection by Type in 2023
Figure 20. Market Size Share of Cell-free Tumor DNA Detection by Type (2019-2024)
Figure 21. Market Size Market Share of Cell-free Tumor DNA Detection by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell-free Tumor DNA Detection Market Share by Application
Figure 24. Global Cell-free Tumor DNA Detection Sales Market Share by Application (2019-2024)
Figure 25. Global Cell-free Tumor DNA Detection Sales Market Share by Application in 2023
Figure 26. Global Cell-free Tumor DNA Detection Market Share by Application (2019-2024)
Figure 27. Global Cell-free Tumor DNA Detection Market Share by Application in 2023
Figure 28. Global Cell-free Tumor DNA Detection Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell-free Tumor DNA Detection Sales Market Share by Region (2019-2024)
Figure 30. North America Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell-free Tumor DNA Detection Sales Market Share by Country in 2023
Figure 32. U.S. Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell-free Tumor DNA Detection Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell-free Tumor DNA Detection Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell-free Tumor DNA Detection Sales Market Share by Country in 2023
Figure 37. Germany Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell-free Tumor DNA Detection Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell-free Tumor DNA Detection Sales Market Share by Region in 2023
Figure 44. China Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell-free Tumor DNA Detection Sales and Growth Rate (K Units)
Figure 50. South America Cell-free Tumor DNA Detection Sales Market Share by Country in 2023
Figure 51. Brazil Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell-free Tumor DNA Detection Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell-free Tumor DNA Detection Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell-free Tumor DNA Detection Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell-free Tumor DNA Detection Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cell-free Tumor DNA Detection Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cell-free Tumor DNA Detection Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cell-free Tumor DNA Detection Market Share Forecast by Type (2025-2030)
Figure 65. Global Cell-free Tumor DNA Detection Sales Forecast by Application (2025-2030)
Figure 66. Global Cell-free Tumor DNA Detection Market Share Forecast by Application (2025-2030)
